# Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)

> **NCT06432569** · NA · COMPLETED · sponsor: **University of Padova** · enrollment: 50 (actual)

## Conditions studied

- Irritable Bowel Syndrome With Diarrhea

## Interventions

- **DIETARY_SUPPLEMENT:** ButirBioma + PeaBioma
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06432569
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-08
- **Primary completion:** 2025-07-07
- **Final completion:** 2025-07-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06432569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06432569, "Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06432569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*